← Back to marketplace
QSBS RolloverClosing Soon
Meridian Cardiac AI
Medtech · Boston, MA · Series A
§1045 window31 days left
AI-guided cardiac imaging platform expanding a Series A round with a dedicated allocation for Section 1045 rollover investors. Newly issued C-corp common qualifies as replacement QSBS.
Highlights
- FDA 510(k) cleared core product with 40+ hospital deployments
- Structured for same-day closing to fit tight 60-day windows
- Company counsel provides QSBS qualification representations at close
Deal terms
- Minimum investment
- $50K
- Raise target
- $8M
- Stage
- Series A
- Gross assets at issuance
- $22M
- Sector
- Medtech
- Location
- Boston, MA
- QSBS regime
- Post-OBBBA (issued after Jul 4, 2025)
- Status
- Closing Soon
This listing is informational only and is not an offer to sell or a solicitation of an offer to buy securities. Any offering is made only to accredited investors through the issuer's own offering documents. QSBS Invest has not verified the issuer's Section 1202 qualification. Confirm eligibility with your own tax and legal advisors before investing.